创新药ETF天弘：7月29日融资净买入473.82万元，连续3日累计净买入611.72万元

Group 1 - The core point of the news is that Tianhong Innovation Drug ETF (517380) has seen significant net buying activity, with a net purchase of 473.82 million yuan on July 29, 2025, and a cumulative net buying of 611.72 million yuan over the last three trading days [1][2][3] - The financing balance on July 29, 2025, reached 779.79 million yuan, which is an increase of 154.86% compared to the previous day [2][3] - The financing net purchases have shown a consistent upward trend over the past few trading days, indicating a strong buying sentiment among investors [1][2] Group 2 - The financing net purchases for the previous trading days were 117.34 million yuan on July 28, 2025, and 20.56 million yuan on July 25, 2025, reflecting increasing investor interest [2][3] - The financing balance has increased significantly from 137.77 million yuan on July 23, 2025, to 779.79 million yuan on July 29, 2025, indicating a shift in market sentiment towards a stronger buying position [2][3] - There were no short selling transactions on July 29, 2025, suggesting a focus on buying rather than selling in the market [1]